Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Rating) was the target of a significant increase in short interest during the month of December. As of December 30th, there was short interest totalling 1,372,200 shares, an increase of 2,081.6% from the December 15th total of 62,900 shares. Based on an average daily volume of 347,700 shares, the short-interest ratio is currently 3.9 days.
Mayne Pharma Group Price Performance
MAYNF stock remained flat at $0.15 on Tuesday. 300 shares of the company traded hands, compared to its average volume of 2,325. Mayne Pharma Group has a fifty-two week low of $0.12 and a fifty-two week high of $0.29. The stock's fifty day moving average is $0.16 and its two-hundred day moving average is $0.19.
Get Mayne Pharma Group alerts:Mayne Pharma Group shares are going to reverse split before the market opens on Wednesday, January 18th. The 1-20 reverse split was announced on Wednesday, January 18th. The number of shares owned by shareholders will be adjusted after the market closes on Wednesday, January 18th.
Mayne Pharma Group Company Profile
(Get Rating)Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products.
Read More
- Get a free copy of the StockNews.com research report on Mayne Pharma Group (MAYNF)
- United Airlines Soars Ahead of Earnings...Time to Deplane?
- Is Dividend King PPG Industries A Buy Before Earnings?
- Shocking New Documentary Exposes The Two Men Destroying America
- 3 Dividend Stocks For Passive Income
- UnitedHealth Group Stock: Is This The Bottom?
Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.